FDA Export Reform and Enhancement Act of 1995: hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995, Volume 4
U.S. G.P.O., 1995 - Business & Economics - 59 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Patricciani John C M D vice president Genetics Institute Inc Cambridge
Statements articles publications letters etc
Other editions - View all
active ingredient advanced medical approval process bill bulk drug substance capital Chairman Chief Operating Officer citizens clinical trials committee competitive Congress cost Cozaar current export current law Dean delays device companies Diatech Drug Export Act effect Europe European Export Act Amendments export applications export approval Export Certificate export controls FDA approval FDA reform FDA's Ferguson foreign countries Fosamax Fred Upton Genetics Institute global important investment issue Judd Gregg Knudson leadership legislation Mark Knudson marketplace MDMA medical device industry medical device manufacturers medical products medical technology Medicare Medtronic ment Merck Orrin Hatch overseas PAUL SIMON Petricciani Prepared Statement problem proval regulation regulatory system requirements safety Section Senator Gregg Senator Hatch Senator Simon start-up Thank Thompson tion U.S. approval U.S. companies U.S. manufacturers U.S. market U.S. medical device U.S. Senate unapproved United World Trade Organization